Borrelia miyamotoi Serology in a Clinical Population with Persistent Symptoms and Suspected Tick-Borne Illness

CME Pending. This course by Dr. Shannon Delaney, a Columbia-trained psychiatrist physician, illuminates key insights from her study "Borrelia miyamotoi Serology in a Clinical Population With Persistent Symptoms and Suspected Tick-Borne Illness.” 

Instructor

Shannon Delaney, MD, MA

Description

This course illuminates key insights from the study “Borrelia miyamotoi Serology in a Clinical Population With Persistent Symptoms and Suspected Tick-Borne Illness.” Physicians will learn about Borrelia miyamotoi, a spirochetal bacterium causing relapsing fever transmitted by Ixodes ticks. Clinicians will further understand the findings of the study illuminating that B. miyamotoi-positive patients have more severe symptoms compared to those with Lyme disease, underscoring the need for increased awareness and testing for this tick-borne disease.

Learning objectives

  1. Include B. miyamotoi in the differential diagnosis of patients with suspected tick-borne illness
  2. Use appropriate testing to identify B. miyamotoi infection
  3. Integrate the symptoms of B. miyamotoi in the evaluation

CME Pending

Application for CME credit has been filed with the American Academy of Family Physicians. Determination of credit is pending.

References

1. Fukunaga M, Takahashi Y, Tsuruta Y, Matsushita O, Ralph D, McClelland M, et al. Genetic and phenotypic analysis of Borrelia miyamotoi sp. nov., isolated from the ixodid tick Ixodes persulcatus, the vector for Lyme disease in Japan. Int J Syst Bacteriol. (1995) 45:804–10. doi: 10.1099/00207713-45-4-804

CrossRef Full Text | Google Scholar

2. Platonov AE, Karan LS, Kolyasnikova NM, Makhneva NA, Toporkova MG, Maleev V V, et al. Humans infected with relapsing fever spirochete Borrelia miyamotoi, Russia. Emerg Infect Dis. (2011) 17:1816–23. doi: 10.3201/eid1710.101474

PubMed Abstract | CrossRef Full Text | Google Scholar

3. Fiorito TM, Reece R, Flanigan TP, Silverblatt FJ. Borrelia miyamotoi polymerase chain reaction positivity on a tick-borne disease panel in an endemic region of Rhode Island. Infect Dis Clin Pract. (2017) 25:250–4. doi: 10.1097/IPC.0000000000000509

CrossRef Full Text | Google Scholar

4. Koetsveld J, Kolyasnikova NM, Wagemakers A, Stukolova OA, Hoornstra D, Sarksyan DS, et al. Serodiagnosis of Borrelia miyamotoi disease by measuring antibodies against GlpQ and variable major proteins. Clin Microbiol Infect. (2018) 24:1338.e1–7. doi: 10.1016/J.CMI.2018.03.009

PubMed Abstract | CrossRef Full Text | Google Scholar

5. Franck M, Ghozzi R, Pajaud J, Lawson-Hogban NE, Mas M, Lacout A, et al. Borrelia miyamotoi: 43 cases diagnosed in france by real-time PCR in patients with persistent polymorphic signs and symptoms. Front Med. (2020) 7:55. doi: 10.3389/fmed.2020.00055

CrossRef Full Text | Google Scholar

6. Molloy PJ, Telford III SR, Chowdri HR, Lepore TJ, Gugliotta JL, Weeks KE, et al. Borrelia miyamotoi disease in the northeastern United States: a case series. Ann Intern Med. (2015) 163:91–8. doi: 10.7326/M15-0333

PubMed Abstract | CrossRef Full Text | Google Scholar

7. Wagemakers A, Staarink PJ, Sprong H, Hovius JWR. Borrelia miyamotoi: A widespread tick-borne relapsing fever spirochete. Trends Parasitol. (2015) 31:260–9. doi: 10.1016/j.pt.2015.03.008

PubMed Abstract | CrossRef Full Text | Google Scholar

8. Krause PJ, Fish D, Narasimhan S, Barbour AG. Borrelia miyamotoi infection in nature and in humans. Clin Microbiol Infect. (2015) 21:631–9. doi: 10.1016/j.cmi.2015.02.006

PubMed Abstract | CrossRef Full Text | Google Scholar

9. Telford SR, Goethert HK, Molloy PJ, Berardi VP, Chowdri HR, Gugliotta JL, et al. Borrelia miyamotoi disease: neither lyme disease nor relapsing fever. Clin Lab Med. (2015) 35:867–82. doi: 10.1016/j.cll.2015.08.002

PubMed Abstract | CrossRef Full Text | Google Scholar

10. Schwan TG, Schrumpf ME, Hinnebusch BJ, Anderson DE, Konkel ME. GlpQ: an antigen for serological discrimination between relapsing fever and Lyme borreliosis. J Clin Microbiol. (1996) 34:2483–92. doi: 10.1128/jcm.34.10.2483-2492.1996

PubMed Abstract | CrossRef Full Text | Google Scholar

11. Aucott JN, Rebman AW, Crowder LA, Kortte KB. Post-treatment Lyme disease syndrome symptomatology and the impact on life functioning: is there something here? Qual Life Res. (2013) 22:75. doi: 10.1007/S11136-012-0126-6

PubMed Abstract | CrossRef Full Text | Google Scholar

12. Fallon BA, Zubcevik N, Bennett C, Doshi S, Rebman AW, Kishon R, et al. The General Symptom Questionnaire-30 (GSQ-30): A brief measure of multi-system symptom burden in Lyme disease. Front Med. (2019) 6:283. doi: 10.3389/fmed.2019.00283

PubMed Abstract | CrossRef Full Text | Google Scholar

13. Krause PJ, Narasimhan S, Wormser GP, Rollend L, Fikrig E, Lepore T, et al. Human Borrelia miyamotoi infection in the United States. N Engl J Med. (2013) 368:291–3. doi: 10.1056/NEJMc1215469

PubMed Abstract | CrossRef Full Text | Google Scholar

14. Kadkhoda K, Dumouchel C, Brancato J, Gretchen A, Krause PJ. Human seroprevalence of Borrelia miyamotoi in Manitoba, Canada, in 2011–2014: a cross-sectional study. C Open. (2017) 5:E690–3. doi: 10.9778/cmajo.20170070

PubMed Abstract | CrossRef Full Text | Google Scholar

15. Krause PJ, Carroll M, Fedorova N, Brancato J, Dumouchel C, Akosa F, et al. Human Borrelia miyamotoi infection in California: serodiagnosis is complicated by multiple endemic Borrelia species. PLoS ONE. (2018) 13:e0191725. doi: 10.1371/journal.pone.0191725

PubMed Abstract | CrossRef Full Text | Google Scholar

16. Sanchez-Vicente S, Tagliafierro T, Coleman JL, Benach JL, Tokarz R. Polymicrobial nature of tick-borne diseases. MBio. (2019) 10:1–17. doi: 10.1128/mBio.02055-19

PubMed Abstract | CrossRef Full Text | Google Scholar

17. Barbour AG, Bunikis J, Travinsky B, Hoen AG, Diuk-Wasser MA, Fish D, et al. Niche partitioning of Borrelia burgdorferi and Borrelia miyamotoi in the same tick vector and mammalian reservoir species. Am J Trop Med Hyg. (2009) 81:1120–31. doi: 10.4269/ajtmh.2009.09-0208

PubMed Abstract | CrossRef Full Text | Google Scholar

18. Centers for Disease Control and Prevention. Data and Surveillance. Centers for Disease Control and Prevention (2019). Available online at: https://www.cdc.gov/lyme/index.html (accessed November 22, 2019).

19. Breuner NE, Hojgaard A, Replogle AJ, Boegler KA, Eisen L. Transmission of the relapsing fever spirochete, Borrelia miyamotoi, by single transovarially-infected larval Ixodes scapularis ticks. Ticks Tick Borne Dis. (2018) 9:1464–7. doi: 10.1016/j.ttbdis.2018.07.006

PubMed Abstract | CrossRef Full Text | Google Scholar

20. Eisen L. Pathogen transmission in relation to duration of attachment by Ixodes scapularis ticks. Ticks Tick Borne Dis. (2018) 9:535–42. doi: 10.1016/j.ttbdis.2018.01.002

PubMed Abstract | CrossRef Full Text | Google Scholar

21. Breuner NE, Dolan MC, Replogle AJ, Sexton C, Hojgaard A, Boegler KA, et al. Transmission of Borrelia miyamotoi sensu lato relapsing fever group spirochetes in relation to duration of attachment by Ixodes scapularis nymphs. Ticks Tick Borne Dis. (2017) 8:677–81. doi: 10.1016/j.ttbdis.2017.03.008

PubMed Abstract | CrossRef Full Text | Google Scholar

22. Lejal E, Moutailler S, Šimo L, Vayssier-Taussat M, Pollet T. Tick-borne pathogen detection in midgut and salivary glands of adult Ixodes ricinus. Parasit Vectors. (2019) 12:1–8. doi: 10.1186/s13071-019-3418-7

PubMed Abstract | CrossRef Full Text | Google Scholar

23. Dworkin MS, Schwan TG, Anderson DE. Tick-borne relapsing fever in North America. Med Clin North Am. (2002) 86:417–33. doi: 10.1016/S0025-7125(03)00095-6

PubMed Abstract | CrossRef Full Text | Google Scholar

24. Forrester JD, Kjemtrup AM, Fritz CL, Marsden-Haug N, Nichols JB, Tengelsen LA, et al. Tickborne relapsing fever–United States, 1990–2011. MMWR Morb Mortal Wkly Rep. (2015) 64:58–60.

PubMed Abstract | Google Scholar

25. Aucott JN. Posttreatment Lyme disease syndrome. Infect Dis Clin North Am. (2015) 29:309–23. doi: 10.1016/j.idc.2015.02.012

PubMed Abstract | CrossRef Full Text | Google Scholar

26. Molloy PJ, Weeks KE, Todd B, Wormser GP. Seroreactivity to the C6 peptide in Borrelia miyamotoi infections occurring in the Northeastern United States. Clin Infect Dis. (2017) 66:1407–10. doi: 10.1093/cid/cix1023

PubMed Abstract | CrossRef Full Text | Google Scholar

27. Talagrand-Reboul E, Boyer PH, Bergström S, Vial L, Boulanger N. Relapsing fevers: neglected tick-borne diseases. Front Cell Infect Microbiol. (2018) 8:98. doi: 10.3389/fcimb.2018.00098

PubMed Abstract | CrossRef Full Text | Google Scholar

About Instructor

Not Enrolled

Course Includes

  • 1 Lesson
  • 2 Quizzes
  • Course Certificate